Although no differences were evident in PSD-95 protein expression, by day 35, the GVHD hippocampus showed a trend toward reduced synaptophysin puncta density compared with TCD BM controls, which was significantly reduced at day 70.
← all excerpts
Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice.
1
—
—